Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Response to Caldera and Vattoth
Camilleri, Michael

American Journal of Gastroenterology | April 21, 2025 | Volume: 120 | Issue: 9 | Pages: 2207-2207

10.14309/ajg.0000000000003441 | PMID 40257104 Get It

Demographics, radiographic characteristics, treatment, and classification of pediatric thumb bony Ulnar Collateral Ligament (UCL) injuries
Lin, James S. , Rowan, Mallory, Samora, Julie Balch

Current Orthopaedic Practice | April 21, 2025 | Volume: 36 | Issue: 4 | Pages: No page available

10.1097/bco.0000000000001307 Get It

Background: Pediatric thumb ulnar collateral ligament (UCL) injuries usually have osseous involvement presenting as a Salter-Harris III avulsion fracture from the base of the proximal phalanx. There is limited guidance about when surgical or non-surgical treatment is more appropriate. Methods: Patients with thumb bony UCL injuries who presented to a large pediatric hospital between 2007 and 2017 were retrospectively identified. Demographics, fracture pattern, treatment, clinical course, and outcomes were collected. Radiographic measurements included size and displacement of fracture fragment as a percentage of the proximal phalanx base articular surface. A classification system was developed incorporating clinical stability of the metacarpophalangeal joint and quantity of displacement. Results: Sixty-five patients were included (47 males and 18 females). The mean age at time of injury was 14.8 SD 1.9 yrs old. 46 (71%) injuries occurred during sporting activities. 50 (77%) patients underwent nonsurgical management with immobilization, and 15 (23%) patients were treated surgically with open reduction internal fixation. For patients treated surgically, the mean fragment size was 28.2% SD 6.8% of the articular surface compared to 14.3% SD 12.5% of those treated non-surgically (P<0.0001). The mean fracture displacement for surgically treated patients was 32.7% SD 19.0% compared to 11.4% SD 7.3% of those treated non-surgically (P<0.0001). Overall, 100% of patients reported they were able to return to their previous level of activity. Conclusion: Many pediatric thumb bony UCL injuries can be treated non-surgically. A classification system based upon joint stability and fracture displacement may help guide appropriate management of these injuries.
The evolving role of minimally invasive glaucoma surgery in glaucoma treatment: A shift toward personalized and predictive medicine
Abubaker, Yazan , Qozat, Ibrahim , Vasu, Pranav, Dorairaj, Syril, Vasu, Pranav , Dorairaj, Emily , Dorairaj, Syril

Kerala Journal of Ophthalmology | April 21, 2025 | Volume: 37 | Issue: 1 | Pages: 4-8

10.4103/kjo.kjo_30_25 Get It

Narrative Exposure Therapy: Expanding Virtual Treatment of Posttraumatic Stress Disorder to the Postpartum Period
Miller, Michelle L. , Jiang, Lily J. , Ward, Marissa J. , Meyer, Danie J., Wasson, Rachel S. , Haas, David M.

Journal of Aggression, Maltreatment & Trauma | April 21, 2025 | Volume: 34 | Issue: 4 | Pages: 538-557

10.1080/10926771.2025.2491772 | PMID 40395722 Get It

Comprehensive Review of the Management of Patients With Acute Cholecystitis Who Are Ineligible for Surgery
Baron, Todd H. , Jorge, Irving , Husnain, Ali , Benias, Petros C. , Bhanushali, Ashok, Docimo, Salvatore , Bloom, Matthew B. , Singh, Harjit , Varadarajulu, Shyam, Reames, Bradley Norman , Salem, Riad , Murphy, Patrick , Riaz, Ahsun

Annals of Surgery | April 21, 2025 | Volume: 283 | Issue: 1 | Pages: 72-81

10.1097/sla.0000000000006741 | PMID 40255177 Get It

Objective: Review the current literature for available treatments for acute cholecystitis (AC) in nonsurgical candidates and provide guidelines for the management of these patients. Background: Cholecystectomy is the gold-standard treatment modality for AC. A considerable number of patients who are not eligible for surgery are managed by percutaneous and endoscopic techniques. There is recent data regarding endoscopic ultrasound-guided gallbladder drainage and emerging percutaneous approaches to address cholelithiasis and remove drains. Methods: An expert panel of surgeons, gastroenterologists, and interventional radiologists reviewed the current literature and provided recommendations for AC management in nonsurgical candidates. Recommendations were based on relevant evidence, with quality and strength assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Results: Percutaneous cholecystostomy is advised for patients ineligible for lumen-apposing metal stent (LAMS) or with reversible conditions, aiming to bridge to cholecystectomy. The optimal timing of cholecystectomy after percutaneous cholecystostomy remains unclear. In cases where surgery is not feasible, potential definitive treatments such as percutaneous cholecystolithotripsy/lithectomy and cholecystoduodenal stenting should be considered. For calculous AC, endoscopic ultrasound-guided gallbladder drainage with LAMS is recommended as a therapy for never-surgical candidates if they are eligible for monitored anesthesia care or general anesthesia and there is institutional expertise and minimal intervening ascites. Conclusions: The management of AC in nonsurgical candidates remains a challenge, with institutional protocols varying based on physician preferences and expertise. The proposed protocol integrates percutaneous and endoscopic approaches and emphasizes the need for multidisciplinary collaboration. Further research is required to evaluate these evolving management techniques, as the current literature is limited.
Finger-in-Glove Appearance of Allergic Bronchopulmonary Aspergillosis in a Chronic Obstructive Pulmonary Disease Patient Without Asthma or Cystic Fibrosis: A Case Report and Literature Review
Lathiya, Maulik , Charokopos, Antonios , Savaliya, Bansi, Madrid, Cristian

No container title available | April 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6115782/v1 Get It

Abstract Background Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to Aspergillus species, commonly observed in patients with asthma or cystic fibrosis. However, its occurrence in individuals with chronic obstructive pulmonary disease (COPD) is rare and not well-documented. Radiological findings such as the "finger-in-glove" sign on computed tomography (CT) scans can aid in diagnosis, but a high index of suspicion is required in atypical cases. ABPA can contribute to mucoid impaction, leading to progressive pulmonary dysfunction if left untreated. Case Presentation We report a unique case of ABPA in a patient with COPD who had no prior history of asthma or cystic fibrosis. The patient presented with worsening respiratory symptoms, and imaging studies revealed mucoid impaction with the characteristic "finger-in-glove" sign. Laboratory findings included peripheral eosinophilia and elevated serum IgE, supporting the diagnosis of ABPA. Management involved antifungal therapy and corticosteroids, followed by a tapering regimen, with prophylactic treatment for pneumocystis pneumonia (PCP) to prevent opportunistic infections. Follow-up pulmonary function tests demonstrated a moderate decline in diffusion capacity, necessitating continued monitoring for potential early interstitial lung disease (ILD) or pulmonary hypertension. Conclusions This case highlights the importance of considering ABPA in patients with COPD who present with mucoid impaction, even in the absence of traditional risk factors. A thorough differential diagnosis of eosinophilia in pulmonary disease is crucial to distinguish between hypersensitivity reactions and malignant myeloproliferative disorders, ensuring appropriate treatment strategies. Clinicians should maintain a high level of awareness for ABPA in COPD patients to facilitate timely diagnosis and management.
Research priorities for adult hospital medicine: A survey of US hospital medicine leaders
Press, Valerie G. , Harrison, James D. , Dugani, Sagar B. , Golden, Blair P. , Caravelli, Nicolas , Jackson‐Sagredo, Andrea, Vaughn, Valerie M. , McWilliams, Andrew , Pavon, Juliessa M. , Jenkins, Ashley , Martinez, Maylyn , Mueller, Stephanie , Jenkins, Ashley M , Prochaska, Micah , Mueller, Stephanie K , Dugani, Sagar B , Vaughn, Valerie M , Sumarsono, Andrew

Journal of Hospital Medicine | April 21, 2025 | Volume: 20 | Issue: 11 | Pages: 1206-1211

10.1002/jhm.70053 | PMID 40254902 Get It

Abstract Hospital medicine (HM), a well‐established clinical specialty, requires clarity of research priorities to identify target areas for investment in HM research infrastructure and activities. The Society of Hospital Medicine's Research Committee developed a 20‐item survey and used purposeful sampling of US hospitalist leaders to prioritize primary research topic domains and subdomains. Respondents were asked to rank their HM research priorities using a scale (1 [highest] to 8 [lowest]). Of 239 surveys distributed, 81 (34%) responded. Respondents were predominantly White (53%) and from academic institutions (57%). “ Overall, 46% of respondents were male and 33% were female. ” Top‐ranked research domains were innovation in care delivery (median 2, IQR 1,3), value‐based care (median 3.5, IQR 2,6), and health disparities (median 4, IQR 2,5). This survey identified top HM research priorities including systems‐based topics and health disparities, aligning with HM's identity as a specialty focused on improving systems of care and inequities in care.
Intraoperative Radiation Therapy (IORT) in Gynecologic Cancers: A Scoping Review
Erdemoğlu, Evrim , Ostby, Stuart A. , Senthilkumar, Sanjanaa , Kumar, Amanika , Vora, Sujay A., James, Sarah E. , Butler, Kristina , Butler, Kristina A., Kumar, Amanika , Chen, Longwen

Cancers | April 20, 2025 | Volume: 17 | Issue: 8 | Pages: 1356

10.3390/cancers17081356 | PMID 40282536 Get It

Objective: We aimed to analyze the current literature for IORT in gynecological cancers and summarized clinical outcomes regarding patient selection. Methods: A systematic search was conducted utilizing PUBMED, Embase, and CINAHL to identify studies following PRISMA-ScR guidelines. A PICOS structure was utilized: population: patients with epithelial gynecological cancers; intervention: IORT; C: a comparator was not required, as we aimed to analyze patient selection; outcome: clinical outcomes and overall survival; and S: experimental and quasi-experimental analytical observational studies and descriptive observational studies, excluding case series published in English and limited to the last 10 years. Data extraction was conducted for patient selection, IORT, oncological outcomes, and morbidity. Results: A total of 707 results were identified, and 509 studies were uploaded to Covidence for screening after removing duplications. Of the 21 eligible studies, 9 were included in the final review. The total number of patients included was 348. The studies were retrospective single-institution studies, except for one. There was significant heterogeneity in their design and protocols. IORT was exclusively used for recurrent and advanced stage gynecological cancers adjunct to pelvic exenteration or laterally extended endopelvic resections with variable indications across institutions. The mean number of IORT patients per study was 2.8 per year. Survival rates were variable and dependent on the surgical margin. Endometrial cancer had a favorable outcome compared to vulvar and cervical cancers. Conclusions: Current clinical practice, as demonstrated by the research, is consistent with NCCN guidelines that endorse the application of IORT in instances of recurrent cervical, vaginal, and vulvar malignancies; however, there are no established recommendations for primary tumors. The analysis shows that there are gaps in our knowledge, mainly regarding the status of the margins, the criteria used to choose patients, and the outcomes that are specific to each histology. The standardization of protocols and prospectively powered studies are needed to refine patient selection criteria.
Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study
Idalsoaga, Francisco , Caldentey, Vicente, Arnold, Jorge , Maiwall, Rakhi , Qian, Steve , Elfeki, Mohamed A. , Khan, Mohammad Qasim, Mortuza, Rokhsana , Malhi, Gurpreet, Islam, Alvi H. , Ramírez, Carolina , Echavarria, Victor, Poca, María , Cuyàs, Berta , Ventura‐Cots, Meritxell , Tijera, María Fátima Higuera-De La, Al‐Karaghouli, Mustafa , Havaj, Daniel Ján , Shah, Vijay H. , Kamath, Patrick S. , SIMONETTO, DOUGLAS, Havaj, Daniel J , Shah, Vijay, Arab, Juan P , Poca, Maria , Ventura Cots, Meritxell , Elfeki, Mohamed A , Cuyas, Berta , Díaz, Luis Antonio , Dunn, Winston , Mehta, Heer, Ayares, Gustavo , Sarin, Shiv Kumar , Zhang, Wei , Simonetto, Douglas A. , Singal, Ashwani K. , Khan, Mohammad Qasim, Guizzetti, Leonardo , Cabezas, Joaquín , Echavarria, Victor, Soriano, German , Abraldeṣ, Juan G. , Skladaný, Lubomir , Rincón, Diego , Arrese, Marco , Bataller, Ramon A , Arab, Juan Pablo

eGastroenterology | April 20, 2025 | Volume: 3 | Issue: 2 | Pages: e100179

10.1136/egastro-2024-100179 | PMID 40276593 Get It

Background Severe alcohol-associated hepatitis (sAH) is a life-threatening condition with high mortality, where corticosteroid use is the only treatment that has shown short-term benefits. Pentoxifylline, an anti-tumour necrosis factor-alpha agent, has been proposed for its potential to improve outcomes, especially in patients with acute kidney injury (AKI). We aimed to evaluate the impact of pentoxifylline on mortality in patients with sAH and AKI in a well-characterised global cohort. Methods We conducted a retrospective, registry-based study including patients meeting the National Institute on Alcohol Abuse and Alcoholism clinical criteria for sAH and AKI. Mortality was the primary endpoint, with liver transplantation as a competing risk. Statistical analysis included Cox regression and Kaplan-Meier survival estimates. Results We included 525 patients from 20 centres across eight countries. The median age was 48 years, with 26.1% females, and 76.9% had a history of cirrhosis. Multivariable Cox regression models showed that pentoxifylline use was not associated with survival (HR 1.20, 95% CI 0.85 to 1.69, p=0.291). Factors associated with mortality included age (HR 1.23, 95% CI 1.10 to 1.36, p<0.001), Model for End-Stage Liver Disease score at admission (HR 1.06, 95% CI 1.04 to 1.08, p<0.001) and renal replacement therapy use (HR 1.39, 95% CI 1.05 to 1.84, p=0.019). The main causes of death were multiple organ failure (42%), infections (10%), oesophageal varices bleeding (7%) and renal failure (6%). Conclusion Pentoxifylline showed no significant benefit on mortality in patients with sAH and AKI. Further studies are needed to refine treatment strategies for this high-risk group.